Scientist Transforms Research into Life-Changing Therapeutics
Aug. 31, 2022
A passion for science and keen grasp of entrepreneurial innovation led Jackson Brougher PhD’22 to help co-found pharmacology startup Doloromics, where he serves as chief scientific officer.
